Potential of George Medicines’ novel, low-dose, triple

Potential of George Medicines’ novel, low-dose, triple

London, UK 24 September 2024 – George Medicines, a late-stage, biopharmaceutical company addressing significant unmet need in the treatment...
1 week ago
from: GlobeNewswire

Continue reading...
Antihypertensive, Hypertension
More about this
- New Hypertension Approach Hits Multiple Targets at Low Dose
Single-pill combinations of three or more antihypertensive drugs are the way forward to help patients reach lower blood pressure targets,...
from: Medscape